Australis Capital Inc.
Australis operates and builds transformative, differentiated cannabis companies predominantly in the United States, a highly-regulated, fragmented, and rapidly expanding industry. Australis adheres to stringent evaluation and operating criteria focusing on high-quality opportunities while maintaining a steadfast commitment to governance and community. Australis' Board and management team have material experience with, and knowledge of, the cannabis space in the U.S., extensive backgrounds in highly-regulated industries and regulatory compliance. Australis operating and portfolio assets include Rthm Technologies Inc., Body and Mind Inc., Quality Green Inc., Folium Biosciences, Mr. Natural Inc., and Green Therapeutics, LLC.. Australis has also developed strategic partnerships with leading innovators such as Wagner Dimas.
Australis Capital Inc. (AUSA)
Le 14 septembre/September 2018
The common shares and warrants of Australis Capital Inc. have been approved for listing on the CSE.
The shares will be listed on September 18, 2018, in anticipation of the completion of the distribution of the common shares and warrants as described in Australis Capital Inc.’s prospectus dated August 14, 2018.
Trading will commence on September 19, 2018 subject to confirmation of closing.